Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neutropenia in Breast Cancer”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Testing effectiveness (Phase 2)Looking for participantsNCT06616987
What this trial is testing

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Yeon Hee Park 40
Not applicableNot Yet RecruitingNCT06076772
What this trial is testing

Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Assiut University 54
Testing effectiveness (Phase 2)UnknownNCT00555516
What this trial is testing

A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy

Who this might be right for
Breast CancerChemotherapyNeutropenia
Tri-Service General Hospital 60
Post-approval studies (Phase 4)Study completedNCT04009941
What this trial is testing

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerNeutropenia
Peking University 104
Not applicableUnknownNCT03618810
What this trial is testing

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

Who this might be right for
Febrile Neutropenia
Zhejiang Cancer Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT03104595
What this trial is testing

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Who this might be right for
Febrile Neutropenia
Enzychem Lifesciences Corporation 28
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT02761460
What this trial is testing

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

Who this might be right for
Breast Cancer
wang shusen 338
Large-scale testing (Phase 3)Study completedNCT01735175
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Who this might be right for
Neutropenic ComplicationsBreast NeoplasmsChemotherapy-induced Neutropenia+1 more
Sandoz 316
Not applicableStudy completedNCT02728596
What this trial is testing

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Who this might be right for
Febrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more
SWOG Cancer Research Network 3,665
Early research (Phase 1)Study completedNCT03376503
What this trial is testing

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

Who this might be right for
Breast Cancer
Nanogen Pharmaceutical Biotechnology Joint Stock Company 24
Not applicableStudy completedNCT01459653
What this trial is testing

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Who this might be right for
Febrile NeutropeniaCancerBreast Cancer+6 more
Sandoz 1,496
Large-scale testing (Phase 3)Study completedNCT01079676
What this trial is testing

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Who this might be right for
Neutropenia in Breast Cancer
Eurofarma Laboratorios S.A. 220
Large-scale testing (Phase 3)Study completedNCT03252431
What this trial is testing

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 393
Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Not applicableStudy completedNCT02921191
What this trial is testing

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Who this might be right for
Breast CancerLung Cancer
Biologics & Biosimilars Collective Intelligence Consortium 57,725
Testing effectiveness (Phase 2)Study completedNCT00771433
What this trial is testing

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeutropenia
Centre Francois Baclesse 120
Large-scale testing (Phase 3)UnknownNCT03294577
What this trial is testing

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 221
Large-scale testing (Phase 3)Study completedNCT03343145
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Who this might be right for
Breast Cancer
Dong-A ST Co., Ltd. 143
Testing effectiveness (Phase 2)Study completedNCT00115414
What this trial is testing

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Who this might be right for
Breast CancerFeverNeutropenia
Amgen
Load More Results